Found 8 matching trials
Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH
PHASE2ENKTL is a highly aggressive non-Hodgkin lymphoma closely related to EBV in...
Location
Department of Medical Oncology,Sun Yat-sen University Cancer Center
L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis
PHASE3This study aimed to investigate the efficacy and safety of Pegaspargase tog...
Location
Beijing Friendship Hospital, Capital Medical University
L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
PHASE3The efficacy and safety of L-DEP (PEG-aspargase, liposomal doxorubicin, eto...
Location
Beijing Friendship Hospital, Capital Medical University
L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH
PHASE3This study aimed to investigate the efficacy and safety of L-DEP (L-Asparag...
Location
Beijing Friendship Hospital, Capital Medical University
Epigenetic Effects of Diesel Exhaust and Ozone Exposure
NAPurpose: The purpose of this protocol is to compare the genetic and epigene...
Location
U.S. EPA Human Studies Facility
Leucine for Depression Study (L-DEP)
EARLY_PHASE1Depression is very common and poses a huge disease burden. About 20% of the...
Location
UCLA Cousins Center for Psychoneuroimmunology
L-DEP as an Initial Treatment for EBV-HLH
PHASE3This study aimed to investigate the efficacy and safety of Pegaspargase tog...
Location
Beijing Friendship Hospital, Capital Medical University
Trial to Incentivise Adherence for Diabetes
NAType II diabetes is associated with a host of adverse and costly complicati...
Location
SingHealth Polyclinics (Geylang)